tipranavir (Compound)

Synonyms:Tipranavir, 174484-41-4, Aptivus, PNU-140690, TPV, UNII-ZZT404XD09, U-140690, CHEBI:63628, ZZT404XD09, 2-Pyridinesulfonamide, N-[3-[(1R)-1-[(6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-, 3'-((1R)-1-((6R)-5,6-Dihydro-4-hydroxy-2-oxo-6-phenethyl-6-propyl-2H-pyran-3-yl)propyl)-5-(trifluoromethyl)-2-pyridinesulfonanilide, N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide, PNU 140690, Aptivus(TM), Tipranavir (INN), Aptivus (TN), Tipranavir [INN:BAN], C31H33F3N2O5S, HSDB 8083, NCGC00182028-01, 2-Pyridinesulfonamide, N-(3-((1R)-1-((6R)-5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, N-{3-[(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulfonamide, U 140690, 1d4y, 2o4l, 2o4n, 2o4p, DSSTox_CID_28548, DSSTox_RID_82820, DSSTox_GSID_48622, SCHEMBL40629, SCHEMBL40630, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, CHEMBL183041, CHEMBL222559, DTXSID6048622, EX-A4113, Tox21_112962, BDBM50479982, AKOS030254403, ZINC100016058, ZINC100022637, CS-1210, DB00932, NCGC00379087-01, NCGC00379087-02, AS-79082, HY-15148, CAS-174484-41-4, X2005, D08605, A811642, Q423404, J-010991, 2-Pyridinesulfonamide, N-(3-(1-(5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)-, (R-(R*,R*))-, N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-phenethyl-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide, N-[3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide, N-[3-[(1R)-1-[(2R)-6-oxidanyl-4-oxidanylidene-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide

Pubchem:PUBCHEM:9830191

Id:7dcb7575-20a6-57a1-828d-8f18b0540277

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View tipranavir's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for tipranavir.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with tipranavir.

Results found

Linked to

	Label	Description
	tipranavir (6cc65933-c4df-45fe-9130-eb6de35eb9ad) Collection (Entity type)	Metadatata for tipranavir
	DCSTRUCT ID 03609 Collection (Entity type)	DrugPage Collection: (DrugCentralID:03609; PubChem_CID:54682461, FILE=drugcentral_drug_03609.json)
	tipranavir negatively regulates ITGB1BP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir negatively regulates GABRP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir negatively regulates ASCL1 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir positively regulates QPRT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir in similarity relationship with 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir in similarity relationship with Nevirapine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir positively regulates GOLT1B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	tipranavir positively regulates MAGEA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

tipranavir (6cc65933-c4df-45fe-9130-eb6de35eb9ad)

Collection (Entity type)

Metadatata for tipranavir

DCSTRUCT ID 03609

Collection (Entity type)

DrugPage Collection: (DrugCentralID:03609; PubChem_CID:54682461, FILE=drugcentral_drug_03609.json)

tipranavir negatively regulates ITGB1BP1

Knowledge Graph Assertion (Entity type)